(Q71581568)
Statements
Suppression of immunopathology in schistosomiasis by interleukin-2-targeted fusion toxin, DAB389IL-2. I. Studies of in vitro and in vivo efficacy (English)
M A Ramadan
N S Gabr
P Bacha
V Günzler
1 December 1995
scientific article published on 01 December 1995
No description defined